CXCR3 antagonist (Boehringer Ingelheim)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCXCR3 antagonist (Boehringer Ingelheim)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 3 antagonists
TargetsC-X-C motif chemokine receptor 3
Therapy Area/IndicationsAutoimmune DiseasesCardiovascular DiseasesLung Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Ingelheim International Gmbh
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesCardiovascular DiseasesLung Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A